ivosidenib

Agios Pharma's Tibsovo Shows Positive Results in Phase III for Another Cancer Indication
BioSpace
Thu, 05/16/19 - 06:44 pm
Agios Pharmaceuticals
Tibsovo
ivosidenib
clinical trials
cholangiocarcinoma
Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Endpoints
Thu, 11/2/17 - 09:56 am
Agios Pharmaceuticals
ASH
FDA
IDH1
ivosidenib